How many insider trades does FilingIQ track for VIVS?

FilingIQ tracks 7 Form 4 insider transactions for VIVS (VivoSim Labs, INC.), covering filings from Nov 17, 2025 onwards. 1 of those were filed in the last 90 days.

Are VIVS insiders net buyers or net sellers?

Across the full Form 4 history for VIVS, 1 transactions (14%) were open-market purchases and 1 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VIVS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VIVS in?

VivoSim Labs, INC. (VIVS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.41M.

VIVS insider trading

NasdaqCM Healthcare

VivoSim Labs, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

14% / 14%

Market cap

$4.41M

About VivoSim Labs, INC.

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Company website: vivosim.ai

VIVS insider activity at a glance

FilingIQ has scored 7 insider transactions for VIVS since Nov 17, 2025. The most recent filing in our index is dated Aug 31, 2026.

Across the full history, 1 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VIVS insider trades is 60.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VIVS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 805

UNITED THERAPEUTICS Corp

BLLN 188

BillionToOne, Inc.

KYMR 166

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

HNGE 122

Hinge Health, Inc.

GH 120

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for VIVS?: FilingIQ tracks 7 Form 4 insider transactions for VIVS (VivoSim Labs, INC.), covering filings from Nov 17, 2025 onwards. 1 of those were filed in the last 90 days.
Are VIVS insiders net buyers or net sellers?: Across the full Form 4 history for VIVS, 1 transactions (14%) were open-market purchases and 1 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VIVS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VIVS in?: VivoSim Labs, INC. (VIVS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.41M.

Methodology & sources

Every VIVS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.